NVO

Novo Nordisk A/S

Healthcare›Drug Manufacturers - General|New York Stock Exchange|DK

Price

$36.98

Market Cap

$164.32B

Beta

0.27

P/E

1.6

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+6.18%

EPS Growth (YoY)+1.81%

Revenue CAGR 3Y+20.34%

P/E Ratio1.6

PEG Ratio—

FCF Yield+34.19%

Debt / Equity0.67

Interest Coverage19.6x

No credit card required

Already have an account? Sign in to view the full analysis for NVO.